Has Amanda Smith received payments from drug or device companies?

Yes. Drug and device makers reported $315 in general payments to Amanda Smith across 18 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amanda Smith did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amanda Smith come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amanda Smith

Psychiatric/Mental Health · Queensbury, NYNPI 1861112757

Payments from drug & device makers

$315in general payments, 2019–2025

Across 18 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$102
Otsuka America Pharmaceutical, Inc.$70
Alkermes, Inc.$37
Takeda Pharmaceuticals U.S.A., Inc.$30
Indivior Inc.$24
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$19
plus $33 from 2 others

What the payments were for

Food & beverage$315100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	5	$102
Otsuka America Pharmaceutical, Inc.	4	$70
Alkermes, Inc.	2	$37
Takeda Pharmaceuticals U.S.A., Inc.	2	$30
Indivior Inc.	1	$24
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$19
Neurocrine Biosciences, Inc.	1	$18
Axsome Therapeutics, Inc.	1	$15

How this compares

$315 in reported general payments places this provider in the 40th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Medicare billing

Part B allowed, 2024

$3,731

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	17	$65,219
VraylarCariprazine Hcl	16	$23,661
Aripiprazole	14	$1,826
Duloxetine Hcl	53	$1,797
Clozapine	13	$1,058
Olanzapine	38	$988
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	16	$974
Bupropion XlBupropion Hcl	42	$908
AmantadineAmantadine Hcl	11	$657
Trazodone Hcl	74	$561
Quetiapine Fumarate	49	$481
Gabapentin	18	$433
Risperidone	34	$373
Prazosin Hcl	18	$370
Lamotrigine	50	$330

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Queensbury

Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K
Daniel BreeyearNiskayuna$149K
Mary OlsonNew York$142K
Elijah StevensBinghamton$131K
Kayanna JonasFar Rockaway$93K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →